Clark Wealth Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Clark Wealth Partners's LLY Position: Q3 2026 in Review
Clark Wealth Partners increased its Eli Lilly (LLY) stake by 5.9% in Q3 2026, buying an estimated $24.8K and bringing the position to 374 shares worth $433K. The position accounts for 0.22% of the portfolio, ranked #50.
Clark Wealth Partners first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Clark Wealth Partners held 374 shares of Eli Lilly worth $433K as of Q3 2026.
- Clark Wealth Partners bought 21 Eli Lilly shares in Q3 2026, an estimated $24.8K.
- Eli Lilly made up 0.22% of Clark Wealth Partners's portfolio in Q3 2026, its #50 holding.
- Clark Wealth Partners first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
- 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Clark Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.